Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Capricor Therapeutics Advances Deramiocel BLA Review Ahead of August 2026 PDUFA Date
Pharma Now Editorial Team
QIAGEN Signs AI Drug Discovery Deal with NVIDIA Integrating BioNeMo Platform
Pharma Now Editorial Team
Other trending news you may like to read
Novartis Presents Actinium-Based RLT Phase 1 Data at ASCO 2026 Alongside Pluvicto and Pipeline Updates
Novartis presents Phase 1 actinium-225 RLT and Pluvicto data at ASCO 2026, raising new manufacturing complexity for radiopharmaceutical facilities.
Pharma Now Editorial Team
Capricor Therapeutics Advances Deramiocel BLA Review Ahead of August 2026 PDUFA Date
Capricor's deramiocel faces an August 22, 2026 PDUFA date as HOPE-3 phase 3 data strengthen the DMD BLA case.
Pharma Now Editorial Team
Infex Therapeutics Achieves Positive Phase IIa Results for RESP-X in Pseudomonas-Colonised Bronchiectasis Patients
Infex Therapeutics reports positive Phase IIa data for RESP-X mAb in NCFB, supporting quarterly dosing and Phase III advancement.
Pharma Now Editorial Team
QIAGEN Signs AI Drug Discovery Deal with NVIDIA Integrating BioNeMo Platform
QIAGEN and NVIDIA integrate BioNeMo AI platform with biomedical knowledge bases to accelerate drug discovery and compress early R&D timelines.
Pharma Now Editorial Team
